COPD Guidelines in the Asia-Pacific Regions: Similarities and Differences

被引:13
作者
Cheng, Shih-Lung [1 ,2 ]
Lin, Ching-Hsiung [3 ,4 ,5 ]
机构
[1] Far Eastern Mem Hosp, Dept Internal Med, Taipei 22060, Taiwan
[2] Yuan Ze Univ, Dept Chem Engn & Mat Sci, Taoyuan 320315, Taiwan
[3] Changhua Christian Hosp, Dept Internal Med, Div Chest Med, Changhua 50006, Taiwan
[4] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan
[5] MingDao Univ, Dept Recreat & Holist Wellness, Changhua 50006, Taiwan
关键词
COPD guideline; Asia; OBSTRUCTIVE PULMONARY-DISEASE; LUNG-DISEASE; GOLD CLASSIFICATION; PRIMARY-CARE; LIFE CARE; OF-LIFE; HEALTH; FLUTICASONE; PREVALENCE; DIAGNOSIS;
D O I
10.3390/diagnostics11071153
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease that is associated with significant morbidity and mortality, giving rise to an enormous social and economic burden. The Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (GOLD) report is one of the most frequently used documents for managing COPD patients worldwide. A survey was conducted across country-level members of Asia-Pacific Society of Respiratory (APSR) for collecting an updated version of local COPD guidelines, which were implemented in each country. This is the first report to summarize the similarities and differences among the COPD guidelines across the Asia-Pacific region. The degree of airflow limitation, assessment of COPD severity, management, and pharmacologic therapy of stable COPD will be reviewed in this report.
引用
收藏
页数:11
相关论文
共 43 条
  • [1] Primary care physician perceptions on the diagnosis and management of chronic obstructive pulmonary disease in diverse regions of the world
    Aisanov, Zaurbek
    Bai, Chunxue
    Bauerle, Otto
    Colodenco, Federico D.
    Feldman, Charles
    Hashimoto, Shu
    Jardim, Jose
    Lai, Christopher K. W.
    Laniado-Laborin, Rafael
    Nadeau, Gilbert
    Sayiner, Abdullah
    Shim, Jae Jeong
    Tsai, Ying Huang
    Walters, Richard D.
    Waterer, Grant
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2012, 7 : 271 - 282
  • [2] [Anonymous], 2015, GLOBAL STRATEGY DIAG
  • [3] Expert consensus on acute exacerbation of chronic obstructive pulmonary disease in the People's Republic of China
    Cai, Bai-qiang
    Cai, Shao-xi
    Chen, Rong-chang
    Cui, Li-ying
    Feng, Yu-lin
    Gu, Yu-tong
    Huang, Shao-guang
    Liu, Rong-yu
    Liu, Guang-nan
    Shi, Huan-zhong
    Shi, Yi
    Song, Yuan-lin
    Sun, Tie-ying
    Wang, Chang-zheng
    Wang, Jing-lan
    Wen, Fu-qiang
    Xiao, Wei
    Xu, Yong-jian
    Yan, Xi-xin
    Yao, Wan-zhen
    Yu, Qin
    Zhang, Jing
    Zheng, Jin-ping
    Liu, Jie
    Bai, Chun-xue
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014, 9 : 381 - 395
  • [4] Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial
    Calverley, P
    Pauwels, R
    Vestbo, J
    Jones, P
    Pride, N
    Gulsvik, A
    Anderson, J
    Maden, C
    [J]. LANCET, 2003, 361 (9356) : 449 - 456
  • [5] Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
    Calverley, Peter M. A.
    Anderson, Julie A.
    Celli, Bartolome
    Ferguson, Gary T.
    Jenkins, Christine
    Jones, Paul W.
    Yates, Julie C.
    Vestbo, Jorgen
    Calverley, P. M. A.
    Anderson, J. A.
    Celli, B.
    Ferguson, G. T.
    Jenkins, C.
    Jones, P. W.
    Knobil, K.
    Yates, J. C.
    Vestbo, J.
    Cherniack, R.
    Similowski, T.
    Cleland, J.
    Whitehead, A.
    Wise, R.
    McGarvey, L.
    John, M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) : 775 - 789
  • [6] Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease - Results from the TORCH study
    Celli, Bartolome R.
    Thomas, Nicola E.
    Anderson, Julie A.
    Ferguson, Gary T.
    Jenkins, Christine R.
    Jones, Paul W.
    Vestbo, Jorgen
    Knobil, Katharine
    Yates, Julie C.
    Calverley, Peter M. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 178 (04) : 332 - 338
  • [7] COPD in Taiwan: a National Epidemiology Survey
    Cheng, Shih-Lung
    Chan, Ming-Cheng
    Wang, Chin-Chou
    Lin, Ching-Hsiung
    Wang, Hao-Chien
    Hsu, Jeng-Yuan
    Hang, Liang-Wen
    Chang, Chee-Jen
    Perng, Diahn-Warng
    Yu, Chong-Jen
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 2459 - 2467
  • [8] Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population: The cross-sectional BOLD study
    Cooksley, Nathania A. J. B.
    Atkinson, David
    Marks, Guy B.
    Toelle, Brett G.
    Reeve, David
    Johns, David P.
    Abramson, Michael J.
    Burton, Deborah L.
    James, Alan L.
    Wood-Baker, Richard
    Walters, E. Haydn
    Buist, A. Sonia
    Maguire, Graeme P.
    [J]. RESPIROLOGY, 2015, 20 (05) : 766 - 774
  • [9] Chronic obstructive pulmonary disease in China: a nationwide prevalence study
    Fang, Liwen
    Gao, Pei
    Bao, Heling
    Tang, Xun
    Wang, Baohua
    Feng, Yajing
    Cong, Shu
    Juan, Juan
    Fan, Jing
    Lu, Ke
    Wang, Ning
    Hu, Yonghua
    Wang, Linhong
    [J]. LANCET RESPIRATORY MEDICINE, 2018, 6 (06) : 421 - 430
  • [10] COPD in China The Burden and Importance of Proper Management
    Fang, Xiaocong
    Wang, Xiangdang
    Bai, Chunxue
    [J]. CHEST, 2011, 139 (04) : 920 - 929